RESUMEN
In the infertility clinic of Abha Hospital which is affiliated to Abha Medical School of King Saud University, 20 hyperprolactinaemic patients became pregnant after receiving treatment with the dopamine agonist bromocryptine. The bromocryptine was used until the 36th week of pregnancy and was then stopped. All the pregnancies except one, continued uneventfully until term and resulted in normal babies, although the methods of delivery were different. All infants were examined by a paediatrician at birth and were followed for a period varying between 6 months and 3 years. These babies have not, to date, shown any abnormality in growth or physical or intellectual abilities. The result of this small study refutes the categorical misconception which was prevailing a few years ago that bromocryptine is teratogenic and should be stopped as soon as pregnancy is diagnosed. The study also showed that bromocryptine is relatively safe even when used until the 36th week of pregnancy